Non-selective beta-blockers in the prevention of first variceal bleeding. Is there any definite alternative?
- 30 September 2002
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (3) , 393-395
- https://doi.org/10.1016/s0168-8278(02)00244-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Endoscopic Ligation Compared with Combined Treatment with Nadolol and Isosorbide Mononitrate to Prevent Recurrent Variceal BleedingNew England Journal of Medicine, 2001
- Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertensionJournal of Hepatology, 2000
- Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST StudyHepatology, 2000
- Pharmacological Treatment of Portal Hypertension: An Evidence-Based ApproachSeminars in Liver Disease, 1999
- Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal RebleedingNew England Journal of Medicine, 1996
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesNew England Journal of Medicine, 1991
- Propranolol Compared with Propranolol plus Isosorbide-5-Mononitrate for Portal Hypertension in CirrhosisAnnals of Internal Medicine, 1991
- Enhancement of Portal Pressure Reduction by the Association of Isosorbide–5–Mononitrate to Propranolol Administration in Patients With CirrhosisHepatology, 1990
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988